Argenx Se (ARGX) Exchange Rate Effect (2020 - 2025)
Argenx Se (ARGX) posted Exchange Rate Effect of $138.6 million for Q4 2025, down 99.9% on a QoQ basis from $133.3 billion in Q2 2025, and up 9.25% year-over-year from $126.8 million in Q4 2024.
Argenx Se (ARGX) Exchange Rate Effect (2020 - 2025) Analysis & Trends
Argenx Se's Exchange Rate Effect history runs 6 years deep, the most recent figure standing at $138.6 million for Q4 2025.
- Quarterly Exchange Rate Effect rose 9.25% year-over-year to $138.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $138.6 million (up 9.25% YoY) and the FY2025 annual result came in at $138.6 million, up 9.25% from the prior year.
- Exchange Rate Effect was $138.6 million for Q4 2025 at Argenx Se, down from $133.3 billion in the prior quarter.
- Across five years, Exchange Rate Effect topped out at $133.3 billion in Q2 2025 and bottomed at $126.8 million in Q4 2024.
- A 5-year average of $13.5 billion and a median of $130.8 million in 2023 frame the typical range for Exchange Rate Effect.
- Annual changes were most pronounced in 2024 — Exchange Rate Effect dropped 3.58% — and 2025, when it surged 103322.65%.
- Argenx Se's Exchange Rate Effect stood at $131.7 million in 2021, then fell by 1.83% to $129.3 million in 2022, then increased by 1.75% to $131.5 million in 2023, then dropped by 3.58% to $126.8 million in 2024, then advanced by 9.25% to $138.6 million in 2025.
- Business Quant data shows ARGX's Exchange Rate Effect at $138.6 million in Q4 2025, $133.3 billion in Q2 2025, and $126.8 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 619,347.27 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 19.32 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | -40.30 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -900,000.00 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Alnylam Pharmaceuticals | 36.08 Bn | 33.07 Bn | 959.66 Mn | -7.06 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 138.57 Mn |
| Dec 31, 2025 | 138.57 Mn |
| Jun 30, 2025 | 133.35 Bn |
| Jun 30, 2025 | 133.35 Bn |
| Dec 31, 2024 | 126.83 Mn |
| Dec 31, 2024 | 126.83 Mn |
| Jun 30, 2024 | 128.94 Mn |
| Jun 30, 2024 | 128.94 Mn |
| Dec 31, 2023 | 131.54 Mn |
| Dec 31, 2023 | 131.54 Mn |
| Jun 30, 2023 | 130.04 Mn |
| Jun 30, 2023 | 130.04 Mn |
| Dec 31, 2022 | 129.28 Mn |
| Dec 31, 2022 | 129.28 Mn |
| Jun 30, 2022 | 128.69 Mn |
| Jun 30, 2022 | 128.69 Mn |
| Dec 31, 2021 | 131.68 Mn |
| Dec 31, 2021 | 131.68 Mn |
| Jun 30, 2021 | 133.16 Mn |
| Jun 30, 2021 | 133.16 Mn |